AkesoGenX's Unattributed - II Round

AkesoGenX raised a round of funding on January 17, 2014.

AkesoGenX bring to market significant new nano-diagnostic and nano-therapeutic medical products. The primary goal is to move the Kanzius RF field treatment forward to treat patients with highly lethal…

Articles about AkesoGenX's Unattributed - II Round: